Navigation Links
Pharmos Corporation Announces Receipt of Nasdaq Delisting Determination
Date:3/6/2009

ublic accounting firm, that expresses doubt about the ability of the company to continue as a going concern for a reasonable period of time.

As previously disclosed, the company is seeking to raise the additional capital necessary to complete the Dextofisopam Phase 2b trial. Assuming a financing is successful, the top line clinical data are expected to be available before the end of 2009.

About Pharmos Corporation

Pharmos discovers and develops novel therapeutics to treat a range of indications including specific diseases of the nervous system such as disorders of the brain-gut axis (IBS), pain/inflammation, and autoimmune disorders. The Company's lead product in development, dextofisopam, is undergoing Phase 2b testing in IBS patients. Dextofisopam has completed a Phase 2a IBS study in which it demonstrated a statistically significant effect compared to placebo on the primary efficacy endpoint of adequate relief (n=141, p=0.033). The Company also has a proprietary technology platform focusing on discovery and development of synthetic cannabinoid compounds with a focus on CB2 receptor selective agonists. Various CB2-selective compounds from Pharmos' pipeline have completed preclinical studies targeting pain, multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and other disorders. These are available for licensing / partnering. On February 18, 2009, Pharmos Corporation and its Israeli subsidiary, Pharmos Ltd., entered into an Asset Purchase Agreement with Reperio Pharmaceuticals Ltd. for the sale of the patent rights and technical know-how related to the compound known as PRS-639,058 and certain follow-on molecules.

Safe Harbor Statement

Statements made in this press release related to the business outlook and future financial performance of Pharmos, to the prospective market penetration of its drug products, to the development and commerci
'/>"/>

SOURCE Pharmos Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Pharmos Corporation Announces Modification to Dextofisopam Trial Size, Objectives Can Still Be Achieved
2. Pharmos Corporation Announces Receipt of Nasdaq Noncompliance Letter
3. Pharmos Corporation Reports 2008 Third Quarter Results
4. Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results
5. Pharmos Restructures Operations in Israel
6. Santa Monica Media Corporation Files Extension Proxy With SEC to Complete Transaction
7. Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31, 2008 Results
8. Sysmex Corporation Announces Organizational Changes
9. Digirad Corporation Sells Arizona, Nevada Service Hubs
10. CVS Caremark Corporation Announces Quarterly Dividend
11. AMERIGROUP Corporation to Present at the Barclays Capital Global Healthcare Conference on March 10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... using intact cells to treat and cure disease ... it is hindered by the inability of doctors and ... of these cells in patients without resorting to invasive ... September 17 in the online journal Magnetic Resonance ... San Diego School of Medicine, University of Pittsburgh and ...
(Date:9/19/2014)... published today in the online journal PLoS Outbreaks ... West Africa by the end of the month if ... State University and Harvard University researchers also discovered through ... significantly increased in August in Liberia and Guinea, around ... place, indicating that the mass quarantine efforts may have ...
(Date:9/19/2014)... Fla. Researchers at Jacksonville,s campus of Mayo Clinic ... they say contributes to both overproduction of toxic protein ... as well as loss of communication between neurons ... Their study, in the online issue of ... specific defect with drugs "may rejuvenate or rescue this ...
(Date:9/19/2014)... Sept. 19, 2014 (HealthDay News) -- When it comes ... in the United States, while the District of Columbia ... the past decade, deaths from gun-related violence -- including ... the United States, the study revealed. Hawaii,s rate was ... of the spectrum, the District of Columbia had the ...
(Date:9/19/2014)... (Sept. 19, 2014) Shahram Majidi, M.D., a ... the George Washington University School of Medicine and ... American Heart Association to study the presence of ... intracerebral hemorrhage (ICH). , "According to epidemiological studies, ... of all strokes, but is the least treatable ...
Breaking Medicine News(10 mins):Health News:A better way to track emerging cell therapies using MRIs 2Health News:Research predicts possible 6,800 new Ebola cases this month 2Health News:Mayo researchers reveal pathway that contributes to Alzheimer's disease 2Health News:U.S. Gun Deaths Lowest in Hawaii, Highest in D.C. 2Health News:GW researcher receives grant to study brain swelling following bleeding in the brain 2
... Stem cell research holds promise for improving the quality of ... develop into any tissue in the human body. However, basic ... researchers are leading the way to inventive solutions. ... and safe therapeutic tool, we have to find strategies to ...
... cafeterias and other food-service providers? A new study from North ... cameras in commercial kitchens to see how precisely food handlers ... more often than previously thought. "Meals prepared outside the ... food poisoning outbreaks, making them a vital focus area for ...
... U.S. Food and Drug Administration,s abilities to discover potential ... illness are hampered by impediments to efficient use of ... and using information on risks, says a new report ... To more proactively tackle food safety problems, ...
... is influenced by our personality traits, according to new research ... published yesterday (7 June 2010) in the Proceedings of ... higher levels of neuroticism and more extravert men, are likely ... societies with traditionally high birth rates. The study ...
... extra sleep over an extended period of time improves ... abstract that will be presented Tuesday, June 8, 2010, ... annual meeting of the Associated Professional Sleep Societies LLC. ... significantly after seven to eight weeks of sleep extension. ...
... for patients in just the first six months after they ... in Canada, according to a study presented today at the ... Ischemic Stroke (BURST) study found that the direct and indirect ... in the six-month period following a new stroke. There are ...
Cached Medicine News:Health News:A launchpad for stem cell research 2Health News:Video study finds risky food-safety behavior more common than thought 2Health News:Video study finds risky food-safety behavior more common than thought 3Health News:FDA should adopt risk-based approach to food safety 2Health News:FDA should adopt risk-based approach to food safety 3Health News:Research shows personality can predict fertility 2Health News:Getting extra sleep improves the athletic performance of collegiate football players 2Health News:Cost of caring for stroke patients double that of earlier estimates 2Health News:Cost of caring for stroke patients double that of earlier estimates 3
(Date:9/19/2014)... Sept. 19, 2014  For Cloud Pharmaceuticals, Inc., ... and development, partnering is an integral part of ... design new drugs and identify early stage, preclinical, ... further their development. The company also partners with ... this business model, Cloud Pharmaceuticals will be participating ...
(Date:9/19/2014)... Mich. , Sept. 19, 2014  Diplomat, the ... of David Dreyer to the Board of ... independent director and will also serve as chair of ... almost 30 years of accounting, financial, compliance and operating ... Mr. Dreyer has served as chief financial officer, chief ...
(Date:9/19/2014)... -- Alere Inc. (NYSE: ALR ), a global ... in support of President Barack Obama,s Executive ... leader in rapid diagnostics for infectious disease, we commend ... the serious threat of antibiotic resistance. We look forward ... to promote the development of rapid point-of-care tests that, ...
Breaking Medicine Technology:Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2David Dreyer Appointed to Diplomat Board of Directors 2Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2
... These objectives provide incredible image flatness over ... correction of chromatic aberration throughout the entire,visible ... for routine laboratory work but for photomicrography. ... series have more contrast than the DLL ...
... for this class of objectives. Correction ... with performance similar to the CFI Plan ... for spherical aberration and provide image flatness ... The DL phase contrast objectives in this ...
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark...
... scientist who wants a fully automated, computer-controlled ... high precision Z-focus automated microscope featuring a ... possible to expand the infinity space to ... A five-way automated light path with ...
Medicine Products: